Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Fluciclovine PET/CT for Recurrent Brain Tumor vs Necrosis
NCT03925675Phase 2Withdrawn
- Sponsor
- Loma Linda University
- Start
- Aug 2020
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluciclovine f 18 in glioma, brain metastases, sponsored by Loma Linda University. Planned start Aug 2020; status: withdrawn.
02
Drugs
fluciclovine f 18
03
Conditions
gliomabrain metastases
Beyond the preview
Go deeper on NCT03925675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03925675.